The Benefits and Considerations of FDA Pre-Submission Meetings Navigating the regulatory landscape for medical devices can be complex and challenging. One invaluable tool to streamline this process is the FDA’s Pre-Submission (Pre-Sub) program. This program offers medical device manufacturers an opportunity to engage in early and constructive dialogue with the FDA, potentially smoothing the path…
On January 29, 2025, IMDRF released a significant document titled “Good Machine Learning Practice for Medical Device Development: Guiding Principles.” This publication outlines ten guiding principles designed to promote the development of safe, effective, and high-quality medical devices that incorporate artificial intelligence (AI) and machine learning (ML) technologies. These principles are intended to be applied…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) released a draft guidance aimed at developers of artificial intelligence (AI)-enabled medical devices. This document offers comprehensive recommendations to ensure the safety and effectiveness of AI-driven devices throughout their entire product lifecycle. The guidance emphasizes the importance of transparency and the mitigation of bias…
Have questions or looking for expert guidance in healthcare innovation, AI-driven medical devices, regulatory approvals, or strategic partnerships? We’re here to help.
📩 Contact us today to discuss how we can support your business growth, regulatory needs, or clinical strategy. Your privacy is our priority—any information you provide will be used solely to address your inquiry.
🔹 Let’s transform healthcare together..
